Latest News and Press Releases

First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy Phase I/II trial will assess safety and efficacy of SMART101 in accelerating immune reconstitution to...

Press Release 4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement Company’s proprietary end-to-end...

Patients will benefit if Europe modernizes its policy framework to reflect the distinct promise of cell and gene therapy, the Alliance for Regenerative Medicine will highlight in 29 November EU...

Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference London, UK 7 January 2021 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company...

PRESS RELEASE Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 15...

PRESS RELEASE Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 15...

Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America               Lugano, Switzerland, São Paulo, Brazil, and Buenos Aires,...

CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical raises $100 million in a Series B financing Europe’s largest medical device financing paves way to Versius® commercialisation ...

Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products Lugano, Switzerland, May 24, 2018 – Helsinn, a Swiss...